TY - JOUR
T1 - Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
AU - Govindarajan, Baskaran
AU - Sligh, James E.
AU - Vincent, Bethaney J.
AU - Li, Meiling
AU - Canter, Jeffrey A.
AU - Nickoloff, Brian J.
AU - Rodenburg, Richard J.
AU - Smeitink, Jan A.
AU - Oberley, Larry
AU - Zhang, Yuping
AU - Slingerland, Joyce
AU - Arnold, Rebecca S.
AU - Lambeth, J. David
AU - Cohen, Cynthia
AU - Hilenski, Lu
AU - Griendling, Kathy
AU - Martínez-Diez, Marta
AU - Cuezva, José M.
AU - Arbiser, Jack L.
PY - 2007/3/1
Y1 - 2007/3/1
N2 - Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.
AB - Melanoma is the cancer with the highest increase in incidence, and transformation of radial growth to vertical growth (i.e., noninvasive to invasive) melanoma is required for invasive disease and metastasis. We have previously shown that p42/p44 MAP kinase is activated in radial growth melanoma, suggesting that further signaling events are required for vertical growth melanoma. The molecular events that accompany this transformation are not well understood. Akt, a signaling molecule downstream of PI3K, was introduced into the radial growth WM35 melanoma in order to test whether Akt overexpression is sufficient to accomplish this transformation. Overexpression of Akt led to upregulation of VEGF, increased production of superoxide ROS, and the switch to a more pronounced glycolytic metabolism. Subcutaneous implantation of WM35 cells overexpressing Akt led to rapidly growing tumors in vivo, while vector control cells did not form tumors. We demonstrated that Akt was associated with malignant transformation of melanoma through at least 2 mechanisms. First, Akt may stabilize cells with extensive mitochondrial DNA mutation, which can generate ROS. Second, Akt can induce expression of the ROS-generating enzyme NOX4. Akt thus serves as a molecular switch that increases angiogenesis and the generation of superoxide, fostering more aggressive tumor behavior. Targeting Akt and ROS may be of therapeutic importance in treatment of advanced melanoma.
UR - http://www.scopus.com/inward/record.url?scp=33847417986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847417986&partnerID=8YFLogxK
U2 - 10.1172/JCI30102
DO - 10.1172/JCI30102
M3 - Article
C2 - 17318262
AN - SCOPUS:33847417986
SN - 0021-9738
VL - 117
SP - 719
EP - 729
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -